Article thumbnail

Effects of obesity on bone metabolism

By Jay J Cao


Obesity is traditionally viewed to be beneficial to bone health because of well-established positive effect of mechanical loading conferred by body weight on bone formation, despite being a risk factor for many other chronic health disorders. Although body mass has a positive effect on bone formation, whether the mass derived from an obesity condition or excessive fat accumulation is beneficial to bone remains controversial. The underline pathophysiological relationship between obesity and bone is complex and continues to be an active research area. Recent data from epidemiological and animal studies strongly support that fat accumulation is detrimental to bone mass. To our knowledge, obesity possibly affects bone metabolism through several mechanisms. Because both adipocytes and osteoblasts are derived from a common multipotential mesenchymal stem cell, obesity may increase adipocyte differentiation and fat accumulation while decrease osteoblast differentiation and bone formation. Obesity is associated with chronic inflammation. The increased circulating and tissue proinflammatory cytokines in obesity may promote osteoclast activity and bone resorption through modifying the receptor activator of NF-κB (RANK)/RANK ligand/osteoprotegerin pathway. Furthermore, the excessive secretion of leptin and/or decreased production of adiponectin by adipocytes in obesity may either directly affect bone formation or indirectly affect bone resorption through up-regulated proinflammatory cytokine production. Finally, high-fat intake may interfere with intestinal calcium absorption and therefore decrease calcium availability for bone formation. Unraveling the relationship between fat and bone metabolism at molecular level may help us to develop therapeutic agents to prevent or treat both obesity and osteoporosis

Topics: Review
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2002). 3: Sex steroids and the construction and conservation of the adult skeleton. Endocrine reviews
  2. (1994). AJ: Age-related bone loss in mice is associated with an increased osteoclast progenitor pool. Bone
  3. (2003). Alterations of bone mineral density and bone metabolism in patients with various grades of chronic pancreatitis. Metabolism: clinical and experimental
  4. (2003). BL: Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.
  5. (1993). BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.
  6. (1995). BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. The Journal of clinical investigation
  7. (1999). Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes care
  8. (2006). Bouxsein ML: Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol
  9. (2010). Brief review: glucocorticoid excretion in obesity.
  10. (2006). CH: Biomechanical and molecular regulation of bone remodeling. Annual review of biomedical engineering
  11. (2006). CH: The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. The Journal of biological chemistry
  12. (2002). Cite this article as: Cao: Effects of obesity on bone metabolism.
  13. (1998). Colditz GA: Current estimates of the economic cost of obesity in the United States. Obes Res
  14. (1998). Coppack SW: Adipose tissue as an endocrine and paracrine organ.
  15. (1992). Cundy TF: Determinants of total body and regional bone mineral density in normal postmenopausal women–a key role for fat mass. The Journal of clinical endocrinology and metabolism
  16. (2003). DawsonHughes B: Leptin, body composition and bone mineral density in premenopausal women. Calcif Tissue Int
  17. (1996). DC: Peroxisome proliferator-activated receptorgamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol
  18. (2002). Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med
  19. (2010). Diet-induced obesity alters bone remodeling leading to decreased femoral trabecular bone mass in mice.
  20. (1998). EE: Absorption of fat and calcium by infants fed a milk-based formula containing palm olein.
  21. (1993). Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res
  22. (1992). Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures.
  23. (1992). Fat mass is an important determinant of whole body bone density in premenopausal women but not in men.
  24. (2003). Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. The Journal of clinical investigation
  25. (1999). Flegal KM: Prevalence of overweight and obesity in the United States,
  26. (1998). Flores-Riveros JR: Biological action of leptin as an angiogenic factor.
  27. (1994). Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature
  28. (2000). Gavrilova O: A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes.
  29. (2002). GC: Leptin inhibits osteoclast generation. J Bone Miner Res
  30. (2010). Glucocorticoid-induced bone fragility.
  31. (2009). GQ: Bonemarrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature
  32. (2005). Grinspoon S: Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation.
  33. (2007). Guignandon A: Mechanical loading down-regulates peroxisome proliferator-activated receptor gamma in bone marrow stromal cells and favors osteoblastogenesis at the expense of adipogenesis. Endocrinology
  34. (2002). H: Changes in proinflammatory cytokine activity after menopause. Endocrine reviews
  35. (2003). H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. The Journal of clinical investigation
  36. (2005). Halloran BP: Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. J Bone Miner Res
  37. (2003). Halloran BP: Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J Bone Miner Res
  38. (2009). High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice. Bone
  39. (2005). Hotamisligil GS: Inflammation, stress, and diabetes. The Journal of clinical investigation
  40. (2003). Hotamisligil GS: Obesity-induced inflammatory changes in adipose tissue. The Journal of clinical investigation
  41. (2009). HS: Osteoclastogenesis by bone marrow-derived macrophages is enhanced in obese mice.
  42. (1998). HS: Understanding adipocyte differentiation. Physiol Rev
  43. (2005). I: Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun
  44. (1997). I: Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. The Journal of clinical investigation
  45. (2001). Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord
  46. (2006). Inflammation and metabolic disorders. Nature
  47. (1996). Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor. J Bone Miner Res
  48. (2004). Isales C: Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone
  49. (2000). Karsenty G: Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell
  50. (2004). Karsenty G: Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci USA
  51. (2000). KC: Percent body fat and bone mass in healthy Canadian females 10 to 19 years of age. Bone
  52. (2001). Koplan JP: The continuing epidemics of obesity and diabetes in the United States. JAMA
  53. (2002). Lanyon LE: Mechanical strain and bone cell function: a review. Osteoporos Int
  54. (2004). Lecka-Czernik B: Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell
  55. (2006). Lecka-Czernik B: Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat. Bone
  56. (2007). Lewis RD: Is adiposity advantageous for bone strength? A peripheral quantitative computed tomography study in late adolescent females.
  57. (1998). Life without white fat: a transgenic mouse. Genes Dev
  58. (1999). Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res
  59. (2001). Manning PJ: Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study.
  60. (1999). Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun
  61. (2006). MB: Dietary intakes of fat and antioxidant vitamins are predictors of subclinical inflammation in overweight Swiss children. The American journal of clinical nutrition
  62. (2008). Mechanical strain inhibits adipogenesis in mesenchymal stem cells by stimulating a durable betacatenin signal. Endocrinology
  63. (2001). Minireview: the OPG/RANKL/RANK system. Endocrinology
  64. (2008). ML: Osteocytes, mechanosensing and Wnt signaling.
  65. (2007). Naaz A: Obesity, inflammation, and insulin resistance. Gastroenterology
  66. (1981). Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch Intern Med
  67. (2009). Obesity and the musculoskeletal system. Curr Opin Rheumatol
  68. (2000). Obesity as a medical problem. Nature
  69. (2000). Organization: Obesity: Preventing and managing the global epidemic,
  70. (2007). Osteoporosis and inflammation. Nutr Rev
  71. (1971). Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res
  72. (1997). PJ: Randomised controlled trial of a synthetic triglyceride milk formula for preterm infants. Arch Dis Child Fetal Neonatal Ed
  73. (1996). PJ: Structural position and amount of palmitic acid in infant formulas: effects on fat, fatty acid, and mineral balance.
  74. (2001). Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Jama
  75. (2001). RT: Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology
  76. (1994). RW: Volumetric bone density of the lumbar spine is related to fat mass but not lean mass in normal postmenopausal women. Osteoporos Int
  77. (2005). S: Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. The American journal of clinical nutrition
  78. Serhan CN: Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases.
  79. (1995). Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology
  80. (2000). SM: Overweight and obese children have low bone mass and area for their weight. Int J Obes Relat Metab Disord
  81. (2003). Taback SP: Bone density in a population-based cohort of premenopausal adult women with early onset inflammatory bowel disease.
  82. (2008). Teitelbaum SL: The osteoclast: friend or foe? Annual review of pathology
  83. (2005). The impact of obesity on the musculoskeletal system. International journal of obesity
  84. (2001). The prevalence of osteoporosis: gender and racial comparison. Calcif Tissue Int
  85. (2006). The role of nutrients in bone health, from A to Z. Critical reviews in food science and nutrition
  86. (2002). TJ: Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
  87. (2001). Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice. Calcif Tissue Int
  88. (2008). Update on obesity.
  89. (1998). WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell
  90. (1997). WJ: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell
  91. (2006). Xu X: Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women.